← Back to Search

Behavioural Intervention

HIIT for Obesity

N/A
Recruiting
Led By Joon Young Kim, Ph.D
Research Sponsored by Syracuse University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)
Awards & highlights

Summary

This trial compares the effects of 3 HIIT protocols on cardiometabolic health in people with obesity. Measurements are taken at 3 different time points.

Who is the study for?
This trial is for young adults aged 18 to 25 with obesity, defined as having a BMI of 30 or higher. It's not suitable for individuals who don't meet the age and BMI criteria.Check my eligibility
What is being tested?
The study tests three different high-intensity interval training (HIIT) programs against no exercise in improving heart health and metabolism in obese young adults. Participants will be randomly placed into one of four groups, including a control group, to assess changes before, after intervention, and post two weeks without training.See study design
What are the potential side effects?
While specific side effects are not listed for HIIT, common ones may include muscle soreness, fatigue, and an increased risk of injury if exercises are performed incorrectly.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post test (2 weeks of intervention), training cessation (2 weeks of detraining) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Body mass index
Carotid-femoral Pulse Wave Velocity (cPWV)
Diastolic blood pressure
+13 more

Trial Design

4Treatment groups
Experimental Treatment
Group I: ControlExperimental Treatment1 Intervention
Control group
Group II: 5s HIITExperimental Treatment1 Intervention
5s HIIT group will perform one bout of sprint running for 5-seconds followed by 25-second, resting of total 40 repetition.
Group III: 20s HIITExperimental Treatment1 Intervention
20s HIIT group will perform one bout of sprint running for 20-seconds followed by 100-second, resting of total 10 repetition.
Group IV: 10s HIITExperimental Treatment1 Intervention
10s HIIT group will perform one bout of sprint running for 10-seconds followed by 50-second, resting of total 20 repetition.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
High-Intensity Interval Training (HIIT) is a common treatment for metabolic diseases that involves short bursts of intense exercise followed by rest or low-intensity periods. This approach improves cardiovascular fitness by increasing heart rate and oxygen consumption, which strengthens the heart and enhances circulation. It also boosts lipid metabolism by promoting the breakdown of fats for energy, thereby reducing body fat and improving lipid profiles. Additionally, HIIT helps regulate blood glucose levels by increasing insulin sensitivity and glucose uptake in muscles. These mechanisms are crucial for managing metabolic diseases as they target poor cardiovascular health, dyslipidemia, and impaired glucose metabolism, which are key aspects of these conditions.

Find a Location

Who is running the clinical trial?

Syracuse UniversityLead Sponsor
48 Previous Clinical Trials
117,550 Total Patients Enrolled
Joon Young Kim, Ph.DPrincipal InvestigatorSyracuse University, Departments of Exercise Science

Media Library

HIIT (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05838950 — N/A
Metabolic Diseases Research Study Groups: 5s HIIT, Control, 10s HIIT, 20s HIIT
Metabolic Diseases Clinical Trial 2023: HIIT Highlights & Side Effects. Trial Name: NCT05838950 — N/A
HIIT (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05838950 — N/A
~25 spots leftby Jul 2025